Clinical Trial Update: Study Evaluating the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety and feasibility of platelet-rich plasma for facetogenic low back pain associated with lumbar spondylosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facetogenic Low Back Pain
• Lumbar Spondylosis

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Matthew Pingree | Conditions: Lumbar Spondylosis | Phase 1 | Status: TERMINATED